€
15.69
Mar 28
Business Description
Description
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 1.23 | |||||
Equity-to-Asset | 0.74 | |||||
Debt-to-Equity | 0.11 | |||||
Debt-to-EBITDA | 1.1 | |||||
Interest Coverage | 6.36 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 7.66 | |||||
Beneish M-Score | -2.2 | |||||
WACC vs ROIC |
Growth Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 11.9 | |||||
3-Year EBITDA Growth Rate | 15.7 | |||||
3-Year EPS without NRI Growth Rate | 8.4 | |||||
3-Year FCF Growth Rate | 17.1 | |||||
3-Year Book Growth Rate | 22.7 |
Momentum Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 58.33 | |||||
9-Day RSI | 56.06 | |||||
14-Day RSI | 57.12 | |||||
6-1 Month Momentum % | 64.8 | |||||
12-1 Month Momentum % | 34.91 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.89 | |||||
Quick Ratio | 1.2 | |||||
Cash Ratio | 0.69 | |||||
Days Inventory | 218.29 | |||||
Days Sales Outstanding | 58.84 | |||||
Days Payable | 59.72 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 0.9 | |||||
Dividend Payout Ratio | 0.57 | |||||
3-Year Dividend Growth Rate | 1.1 | |||||
Forward Dividend Yield % | 0.9 | |||||
5-Year Yield-on-Cost % | 0.91 | |||||
3-Year Average Share Buyback Ratio | -0.4 | |||||
Shareholder Yield % | 0.39 |
Profitability Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 61.26 | |||||
Operating Margin % | 11.1 | |||||
Net Margin % | 11.79 | |||||
FCF Margin % | 11.4 | |||||
ROE % | 7.65 | |||||
ROA % | 5.56 | |||||
ROIC % | 4.86 | |||||
ROC (Joel Greenblatt) % | 70.21 | |||||
ROCE % | 8.3 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 66.8 | |||||
PE Ratio without NRI | 66.8 | |||||
Shiller PE Ratio | 66.58 | |||||
Price-to-Owner-Earnings | 63.29 | |||||
PEG Ratio | 3.44 | |||||
PS Ratio | 8.02 | |||||
PB Ratio | 3.96 | |||||
Price-to-Tangible-Book | 35.66 | |||||
Price-to-Free-Cash-Flow | 72.08 | |||||
Price-to-Operating-Cash-Flow | 49.56 | |||||
EV-to-EBIT | 60.3 | |||||
EV-to-EBITDA | 38.74 | |||||
EV-to-Revenue | 8.99 | |||||
EV-to-FCF | 79.02 | |||||
Price-to-Projected-FCF | 2.47 | |||||
Price-to-DCF (Earnings Based) | 1.71 | |||||
Price-to-DCF (FCF Based) | 1.87 | |||||
Price-to-Median-PS-Value | 1.21 | |||||
Price-to-Peter-Lynch-Fair-Value | 4.86 | |||||
Price-to-Graham-Number | 10.32 | |||||
Price-to-Net-Current-Asset-Value | 224.14 | |||||
Earnings Yield (Greenblatt) % | 1.66 | |||||
FCF Yield % | 1.26 | |||||
Forward Rate of Return (Yacktman) % | 15.54 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Biotage AB Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 140.122 | ||
EPS (TTM) (€) | 0.242 | ||
Beta | 1.83 | ||
Volatility % | 35.4 | ||
14-Day RSI | 57.12 | ||
14-Day ATR (€) | 0.351817 | ||
20-Day SMA (€) | 15.5785 | ||
12-1 Month Momentum % | 34.91 | ||
52-Week Range (€) | 7.285 - 16.37 | ||
Shares Outstanding (Mil) | 80.01 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Biotage AB Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Biotage AB Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Biotage AB Frequently Asked Questions
What is Biotage AB(STU:PQX1)'s stock price today?
When is next earnings date of Biotage AB(STU:PQX1)?
Does Biotage AB(STU:PQX1) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |